New insights on the potential effect of orexin receptor antagonist suvorexant on Parkinson's disease symptoms.

Al-Kuraishy, Hayder M; Al-Gareeb, Ali I; Alexiou, Athanasios; Papadakis, Marios; Saad, Hebatallah M; Batiha, Gaber El-Saber

Al-Kuraishy, Hayder M; Al-Gareeb, Ali I; Alexiou, Athanasios; Papadakis, Marios; Saad, Hebatallah M; Batiha, Gaber El-Saber.

Affiliation

Al-Kuraishy HM; Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriyia University, P.O. Box 14132, Baghdad, Iraq.
Al-Gareeb AI; Department of Clinical Pharmacology and Medicine, College of Medicine, Al-Mustansiriyia University, P.O. Box 14132, Baghdad, Iraq.
Alexiou A; Department of Science and Engineering, Novel Global Community Educational Foundation, Hebersham, NSW, 2770, Australia.
Papadakis M; Department of Research & Development, AFNP Med, Wien, 1030, Austria.
Saad HM; University Centre for Research & Development, Chandigarh University, Chandigarh-Ludhiana Highway, Mohali, Punjab, India.
Batiha GE; Department of Research & Development, Funogen, Athens, Greece.

Neurol Sci ; 45(5): 2367-2368, 2024 May.

Article in En | MEDLINE | ID: mdl-38231375

Subject(s)

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Parkinson Disease / Sleep Initiation and Maintenance Disorders Type of study: Diagnostic_studies Limits: Humans Language: En Journal: Neurol Sci / Neurol. sci / Neurological sciences Journal subject: NEUROLOGIA Year: 2024 Document type: Article Affiliation country: Irak Country of publication: Italia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google